NRC Health Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
NRC Health (NRC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 131.01 thousand shares for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2013-03-01
- NRC Health share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2012-12-31 was 262.02K shares.
- NRC Health share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2012-09-30 was -23.51K shares.
- NRC Health share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2012 was 131.01K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2012-12-31 | 262.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | 238.52K shares derived: sum of 2 quarters · filed 2013-03-01 | 131.01K shares 10-K · filed 2013-03-01 | |
| 2012-09-30 | -23.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -131.01K shares 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | -107.50K shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |